Table 3 comparison between the current study and earlier research based on O3-HPCP.
From: Tocilizumab degradation via photo-catalytic ozonation process from aqueous
Processes | pollutants | Optimum condition | Efficiency (%) | Authors and references |
|---|---|---|---|---|
photocatalytic ozonation process—TiO2 magnetic nanoparticles | Ceftazide | CFT concentration = 10 mg/L, pH = 11, catalyst dosage = 1.0 g/L and ozone flow = 0.22 g/h and RT = 15 min | efficiency and mineralization of 100 was 75.5% were obtained | Asgari49 |
photocatalytic ozonation—Bi2WO6 | Tetracycline hydrochloride | Bi2WO6 dose = 0.5 g/L, O3 concentration = 10 mg/L, pH = 3.8, time = 120 min | Over 80% TOC was removed | Lu51 |
photocatalytic ozonation/ | Oxytetracycline | pH 8.0, CD = 0.34 mg/l, RT = 56 min and O3 concentration = 28.7 mN | 96.2, 77.2, 64.2% of OTC, COD, and TOC were removed | Mehralipour20 |
photocatalytic ozonation—ZnO/ICLT nanocomposite | Furosemide (FRS) | O3 = 11 mg/L, FRS = 33.18 mg/L, dose = 0.27 g/L and time = 30 min | 99.8% of FRS was removed | Heidari54 |
Heterogeneous photocatalytic ozonation-Bi2WO6/TiO2 | sulfamethoxazole | catalyst dosage = 0.2 g/L, the ozone concentration = 1.5 mg/L, the SMX concentration = 10 mg/L, the pH = 5.25, and reaction time = 180 min | the removal rate of SMX was 97.1% | Zhang47 |
O3-HPCP/Co-MOF | tocilizumab | pH = 7.0, CD = 0.46 mg/l, RT = 59 min, and O3 concentration = 32 mMol/l | 92, 79.8, and 59% of tocilizumab, COD and TOC were removed | Current study |
